← Evidence map

ReviewCurrent oncology reports2019

Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development.

Mayanne M T Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30659394